8 April, 2021
Cuba advances in scientific studies on colorectal cancer
Cuba advances in scientific studies on colorectal cancer
Cuba advances in scientific studies on colorectal cancer
Cuba and Germany to boost biotechnology and biopharmaceutical cooperation
Cuba insists on raising risk perception regarding Covid-19
The second anti-Covid-19 intervention trial in Cuba is beginning Monday with the vaccine candidate Abdala with 124,000 volunteers, among them health workers and the biopharmaceutical sector.
The export of the first shipment of eco wood or plastic wood marks the incorporation of the non-state, private or private form of management in the province of Sancti Spiritus to the production and export of this product.
The British medical journal The Lancet, one of the most influential peer-reviewed scientific publications globally, recognized Cuba’s long-standing commitment to health, which has led to a successful response to the COVID-19 pandemic.
The Cuban Ministry of Industry is currently leading some 200 science and innovation projects, according to a meeting between President Miguel Díaz-Canel and Prime Minister Manuel Marrero with experts and scientists linked to the sector.
The president of Cuba, Miguel Diaz-Canel, praised the country’s progress in immunizing the population against Covid-19 with the use of vaccine candidates produced by the national biotechnology industry.
Venezuelan President Nicolas Maduro announced Sunday in a television broadcast that his country will join the Phase III clinical trials of the Cuban vaccine candidates Soberana 02 and Abdala.
The third phase of the clinical trials of Abdala Covid-19 vaccine candidate started on Monday in this city and the capital municipalities of Guantanamo and Granma with the injection of the first volunteers.
China and Cuba are developing a vaccine against several SARS-CoV-2 variants. According to the Xinhua news agency, Chinese scientists and Cuban experts of the Center for Genetic Engineering and Biotechnology (CIGB) in Havana are developing the product in a facility opened in the city of Yongzhou, Hunan province (center), for research between both countries.
The Neurology and Neurosurgery Institute of Cuba will start a study, in the next few days, on the neurological manifestations in patients who recovered from Covid-19.
The first baby girl born in Cuba by a caesarean section while her mother was in a critical condition due to complications related to Covid-19, is at home on Saturday with her relatives.
Cuba’s anti-Covid-19 vaccine candidate Soberana 02 (Spanish for ‘sovereign’) is supplementing phase III of its clinical trials in Iran with the arrival of 100,000 doses in that country, BioCubaFarma announced on Friday in this capital.
Cuban President Miguel Diaz-Canel on Wednesday insisted on the protection of children and teenagers against Covid-19, and warned about the sequels of the disease.
Numerous Serbian media today showed Cuba’s progress in developing vaccine candidates against Covid-19 called Soberana 01 and 02, Abdala, Mambisa and Soberana Plus, as well as the ongoing trials.
Cuba seeks to increase the exploitation of hydraulic infrastructure by using efficient irrigation techniques, the Ministry of Agriculture (MINAG) announced on Monday.
Cuba will start administering Nasalferon, a drug produced by the country’s biotechnology industry, to travelers and their relatives in order to prevent the replication of the SARS-CoV-2 coronavirus, and strengthen their immune system.
Cuba and Vietnam strengthened bilateral economic and scientific technical collaboration today, as a result of the 38 session of the intergovernmental commission that met virtually between the Caribbean capital and Hanoi.